Entegris, Inc. — Q3 2011 Form 10-Q
Business context and reporting period. Entegris supplies products and services that purify, protect and transport critical materials, primarily for semiconductor and related high-technology industries. This unaudited filing covers the quarter ended October 1, 2011, and the first nine months of fiscal 2011; comparisons are with the corresponding 2010 periods unless noted.
Financial performance
| Metric | Three months ended Oct. 1, 2011 | Nine months ended Oct. 1, 2011 |
|---|---|---|
| Net sales | $173.0 million; down 3% | $585.3 million; up 16% |
| Gross profit / margin | $74.8 million / 43.2% | $258.3 million / 44.1% |
| Operating income / margin | $26.8 million / 15.5% | $105.2 million / 18.0% |
| Net income attributable to Entegris | $22.0 million; diluted EPS $0.16 | $83.7 million; diluted EPS $0.62 |
| Operating cash flow | Not reported separately for the quarter | $112.8 million |
| Capital expenditures | Not reported separately for the quarter | $24.1 million |
- Compared with Q3 2010, quarterly gross margin fell from 44.8% and operating margin from 16.4%; net income attributable to Entegris decreased from $22.4 million and diluted EPS from $0.17.
- For the first nine months, gross margin fell from 45.5%, while operating margin improved from 15.4%. Net income attributable to Entegris rose from $57.4 million and diluted EPS from $0.43.
- Sequentially, Q3 sales declined 17% from Q2 2011. Excluding favorable currency translation, sales declined approximately 18% sequentially and 8% year over year. Reported year-over-year sales benefited from currency translation of $9.7 million in Q3 and $32.1 million year to date.
- Cash and cash equivalents were $227.0 million, with $2.0 million in short-term investments, at October 1. Working capital was $377.0 million. The company had no short- or long-term debt outstanding.
Material changes and segment results
- Q3 weakness reflected lower semiconductor production and capital investment, reduced customer fab utilization and wafer starts, and lower factory utilization. Management described sales changes as primarily volume-driven and said pricing erosion had been nominal.
- For the first nine months, segment sales were CCS $378.9 million (+19%), Microenvironments $142.0 million (+4%), and Specialty Materials $64.4 million (+24%). Segment profit was $114.2 million, $23.8 million, and $13.9 million, respectively. Microenvironments’ year-to-date profit declined from $31.3 million despite higher sales.
- Quarterly segment sales/profit were: CCS $110.0 million/$29.5 million; Microenvironments $42.7 million/$6.8 million; Specialty Materials $20.3 million/$4.7 million. CCS and Microenvironments sales and profits declined year over year; Specialty Materials improved.
- Operating cash flow increased from $100.9 million to $112.8 million year to date. Property and equipment purchases rose to $24.1 million from $12.2 million. Approximate operating cash flow less capital expenditures was $88.6 million; this is a derived measure, not a company-reported metric.
- Cash and investments increased from $134.0 million at year-end 2010. The company purchased the remaining 30% interest in its Pureline subsidiary for $1.5 million in April and reported all consolidated subsidiaries wholly owned at quarter-end.
Outlook, risks and unusual items
- Management expected 2011 capital expenditures of approximately $30 million and believed available cash, facilities and operating cash flow would meet working-capital and investment needs for the next 12 months. It gave no specific revenue or earnings guidance. Management cautioned that nine-month results are not necessarily indicative of full-year results.
- A new $30 million revolving facility matures June 9, 2014, replacing a $60 million facility. There were no borrowings and no immediate borrowing plans; the company reported compliance with covenants. The facility requires minimum qualifying cash and investments of $25 million, including $10 million held in specified U.S. bank accounts. Two Japanese credit lines, equivalent to approximately $15.6 million, were also undrawn.
- On October 5, after quarter-end, the board authorized repurchases of up to $50 million of common stock. The filing does not state that repurchases had begun.
- Tax expense was $22.6 million year to date, versus $15.2 million. The 21.2% effective tax rate benefited from a $14.9 million reduction in the U.S. deferred-tax-asset valuation allowance, Malaysia tax-holiday benefits and lower tax rates in certain jurisdictions.
- Unusual items included a $0.7 million pension curtailment gain in Q3 following an amendment freezing benefit accruals under the Japan defined-benefit plan; a $1.5 million gain on sale of an equity-method investment in Q2; and lower amortization following the full amortization of certain acquired assets in 2010.
- Key risks include semiconductor-industry cyclicality, competition and pricing pressure, fixed-cost exposure when sales fall, foreign-exchange fluctuations and possible supply-chain or demand effects from the 2011 Japan earthquake and tsunami. About 20% of historical revenue came from Japanese customers. The company reported ordinary-course legal matters that management did not expect to have a material adverse effect.
Important facts for investors to verify
- Whether the Q3 sales decline and reduced factory utilization persisted, and how they affected gross margins and segment profitability.
- The extent to which nine-month earnings benefited from the deferred-tax valuation allowance release and other identified gains or adjustments.
- Whether the board-authorized $50 million repurchase was implemented and how it affected cash and share count.
- Compliance with revolving-facility covenants and the availability of liquidity, including the facility’s cash-location requirements.
- Whether Japan-related supply, customer-demand or currency risks materially changed after the filing date.